LAG3 anticorps (Extracellular Domain)
Aperçu rapide pour LAG3 anticorps (Extracellular Domain) (ABIN6992260)
Antigène
Voir toutes LAG3 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- Extracellular Domain
-
Purification
- LAG-3 Antibody is supplied as protein A purified IgG1.
-
Immunogène
- LAG-3 antibody was raised against the extracellular domain of human LAG-3
-
Isotype
- IgG1 kappa
-
-
-
-
Indications d'application
-
LAG-3 antibody can be used for ELISA starting at 0.25 μ,g/mL. For Western blot start at 0.25 μ,g/mL. For Immunocytochemistry start at 1 μ,g/mL. For Immunofluorescence start at 10 μ,g/mL. For Immunohistochemistry start at 5 μ,g/mL. For Flow Cytometry start at 1 μ,g/mL.
Antibody validated: Western Blot in human samples, Immunohistochemistry in human samples, Immunocytochemistry in human samples, Immunofluorescence in human samples and Flow Cytometry in human samples. All other applications and species not yet tested. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- LAG-3 Antibody is supplied in PBS containing 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,4 °C
-
Stockage commentaire
- LAG-3 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
-
- LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
-
Autre désignation
- LAG3
-
Sujet
- The lymphocyte activation gene-3 (LAG3) is a member of the immunoglobulin superfamily and binds MHC class II with high affinity (1), negatively regulating T-cell function and homeostasis (2). It is expressed in B, T, and NK cells, monocytes, and dendritic cells (3), and acts to regulate T cell expansion (4). LAG3 is also an important immune checkpoint protein, with anti-LAG3 antibodies activating T effector cells and affecting regulatory T cell functions. Furthermore LAG3 appears to act in a synergistic fashion with PD-1/PD-L1, suggesting that a dual antibody approach may prove useful in cancer immunotherapy.
-
Poids moléculaire
-
Predicted: 55 kDa
Observed: 60, 70, 80 kDa -
ID gène
- 3902
-
NCBI Accession
- NP_002277
-
UniProt
- P18627
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Antigène
-